The PlexCMV tests the risk of cytomegalovirus infection and transplant infection by measuring changes in T-cell immunity to the virus, according to an Oct. 17 news release from the company.
The test assesses the risk of losing the transplanted organ and fluctuations of the risk during therapy.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
